相关实验视频

Updated: May 25, 2025

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

通过铁调节抑制中性细胞外细胞陷的形成,用于增强癌症免疫疗法

Jinmin Ye¹, Yatong Qin¹, Hui Liu¹

¹State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory & Center for Molecular Imaging and Translational Medicine, National Innovation Platform for Industry-Education Integration in Vaccine Research, School of Public Health, Xiamen University, Xiamen 361102, China.

|February 26, 2025

概括

我们开发了一种新型的类药物合物 (PDC) 纳米剂,以调节中性粒细胞的铁代谢,抑制中性粒细胞细胞外陷 (NET) 形成并增强抗瘤免疫力. 这一策略为癌症免疫治疗提供了一种新的方法.

科学领域:

生物医学工程生物医学工程
免疫学免疫学免疫学
癌症研究癌症研究

背景情况:

中性细胞细胞外陷 (NET) 形成是瘤微环境中的一个关键的免疫抑制机制.
中性粒细胞中铁代谢的失调有助于NET的形成,并阻碍了抗瘤免疫反应.

研究的目的:

开发一种可转换的铁纳米器 (TIN),以有针对性地调节中性粒细胞的铁代谢.
研究TIN在抑制NET形成和增强抗瘤免疫力的有效性.
评估TIN与其他癌症免疫疗法的协同效应.

主要方法:

开发一种基于-药物合物 (PDC) 的可变铁纳米器 (TIN).
研究TIN的形态转化和铁的化能力.
评估TIN对中性粒细胞外细胞陷 (NET) 在体外和体内形成的影响.
评估TIN与蛋白质氨酸减小酶4抑制剂和抗PD-L1疗法结合的治疗疗效.

主要成果:

该TIN证明了中性粒细胞弹性酶介导的从纳米颗粒转化为纳米纤维的转化,使得特定的铁 (II) 结合.
TIN有效地抑制了中性粒细胞外细胞陷 (NET) 的形成,从而减少了瘤微环境中的免疫抑制.
与TIN的联合治疗协同增强了蛋白质氨酸减小酶4抑制剂和抗PD-L1治疗的抗瘤作用.

结论:

用TIN准中性粒细胞的铁代谢是一种可行的策略,可以抑制NET的形成并克服瘤诱导的免疫抑制.
作为癌症免疫治疗的创新治疗剂,TIN具有前景,特别是在组合疗法中.
这项研究提供了一种新的免疫调节方法,通过向癌症治疗中性粒细胞的铁代谢.

关键词:

癌症免疫疗法免疫疗法铁器规则铁器规则铁器规则一个纳米化器.中性粒细胞外细胞陷酸药物结合物结合物

更多相关视频

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

Neutrophil Extracellular Traps Generated by Low Density Neutrophils Obtained from Peritoneal Lavage Fluid Mediate Tumor Cell Growth and Attachment

Neutrophil Extracellular Traps Generated by Low Density Neutrophils Obtained from Peritoneal Lavage Fluid Mediate Tumor Cell Growth and Attachment

Published on: August 3, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...